On day 1 of the Family Heart Global Summit, speakers highlighted the critical need for awareness, early diagnosis, and innovative treatment options for familial hypercholesterolemia, sharing ...
SHANGHAI, April 2, 2024 /PRNewswire/ -- YolTech Therapeutics announced that the first patient has been dosed with YOLT-101, the company's in vivo genome editing candidate being developed as a single ...
Please provide your email address to receive an email when new articles are posted on . Familial hypercholesterolemia is underdiagnosed and undertreated. A novel machine learning algorithm identified ...
One of the first global snapshots of familial hypercholesterolemia (FH) in children and adolescents reveals challenges in how young people with this fairly common genetic condition are diagnosed, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results